Advertisement
Australia markets close in 30 minutes
  • ALL ORDS

    7,803.10
    -95.80 (-1.21%)
     
  • ASX 200

    7,551.90
    -90.20 (-1.18%)
     
  • AUD/USD

    0.6397
    -0.0029 (-0.45%)
     
  • OIL

    84.63
    +1.90 (+2.30%)
     
  • GOLD

    2,398.40
    +0.40 (+0.02%)
     
  • Bitcoin AUD

    96,952.69
    +927.30 (+0.97%)
     
  • CMC Crypto 200

    1,283.10
    +397.56 (+43.50%)
     
  • AUD/EUR

    0.6014
    -0.0016 (-0.27%)
     
  • AUD/NZD

    1.0880
    +0.0005 (+0.05%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,194.10
    -191.77 (-1.17%)
     
  • NIKKEI 225

    37,113.31
    -966.39 (-2.54%)
     

2 Stocks I'll Hold Forever

2 Stocks I'll Hold Forever

As a major pharma company, AbbVie (NYSE: ABBV) delivers for its investors by developing and commercializing new drugs, like its best-selling arthritis treatment Humira. There's two reasons AbbVie is worth holding forever: its skill with drug development, and its generous dividend. Like many other pharma companies, AbbVie maximizes the revenue that it gets from each of its drug development projects by investigating their usefulness for multiple illnesses.